Data completeness
0/8 — Limited
Drug data last refreshed 2w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
UTICORT (betamethasone benzoate) is a topical corticosteroid lotion indicated for inflammatory and pruritic dermatological conditions. It is a potent glucocorticoid that reduces inflammation, itching, and skin irritation when applied directly to affected areas. The drug works by suppressing local immune and inflammatory responses in the skin.
Pre-Launch
As a pre-launch product, this represents a greenfield commercial opportunity with significant potential for brand building, market education, and field team expansion at Pfizer's dermatology division.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
UTICORT represents a pre-launch career opportunity in Pfizer's dermatology franchise, offering exposure to brand building, field launch execution, and competitive positioning in a crowded topical market. Team size and roles will expand significantly as the product approaches market entry, with emphasis on commercial operations and access strategy.
Brand ManagerField Sales Representative
Worked on UTICORT at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.